Literature DB >> 29732706

Liposomes-Camouflaged Redox-Responsive Nanogels to Resolve the Dilemma between Extracellular Stability and Intracellular Drug Release.

Jinfeng Ma1, Hongzhang Deng1, Fuli Zhao1, Liandong Deng1,2, Weiwei Wang3, Anjie Dong1,2, Jianhua Zhang1,4.   

Abstract

Liposomes have shown great promises for pharmaceutical applications, but still suffer from the poor storage stability, undesirable drug leakage, and uncontrolled drug release. Herein, liposomes-camouflaged redox-responsive nanogels platform (denoted as "R-lipogels") is prepared to integrate the desirable features of sensitive nanogels into liposomes to circumvent their intrinsic issues. The results indicate that drug-loaded R-lipogels with controlled size and high stability not only can achieve a very high doxorubicin (DOX)-loading capacity (12.9%) and encapsulation efficiency (97.3%) by ammonium sulfate gradient method and very low premature leakage at physiological condition, but also can quickly release DOX in the reducing microenvironment of tumor cells, resulting in effective growth inhibition of tumor cells. In summary, the strategy given here provides a facile approach to develop liposomes-nanogels hybrid system with combined beneficial features of stealthy liposomes and responsive nanogels, which potentially resolves the dilemma between systemic stability and intracellular rapid drug release.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  active drug-loading; drug delivery; liposomes; nanogels; redox-sensitive

Mesh:

Substances:

Year:  2018        PMID: 29732706     DOI: 10.1002/mabi.201800049

Source DB:  PubMed          Journal:  Macromol Biosci        ISSN: 1616-5187            Impact factor:   4.979


  3 in total

Review 1.  Hybrid Nanogels: Stealth and Biocompatible Structures for Drug Delivery Applications.

Authors:  Parisa Eslami; Filippo Rossi; Stefano Fedeli
Journal:  Pharmaceutics       Date:  2019-02-07       Impact factor: 6.321

2.  Smart Lipid-Polysaccharide Nanoparticles for Targeted Delivery of Doxorubicin to Breast Cancer Cells.

Authors:  Manuela Curcio; Matteo Brindisi; Giuseppe Cirillo; Luca Frattaruolo; Antonella Leggio; Vittoria Rago; Fiore Pasquale Nicoletta; Anna Rita Cappello; Francesca Iemma
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

3.  Enzyme-triggered- and tumor-targeted delivery with tunable, methacrylated poly(ethylene glycols) and hyaluronic acid hybrid nanogels.

Authors:  Wioletta Liwinska; Ewelina Waleka-Bagiel; Zbigniew Stojek; Marcin Karbarz; Ewelina Zabost
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.